Article

Rabbit Virus Could Be Key to Fighting Brain Cancer Highlights Specialty Pharmacy Week in Review

Author(s):

Carly Szabo, Assistant Editor

Top stories of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/pharmacist-admits-to-14-4-million-medicaid-fraud-h" target="_blank">View the story "Rabbit Virus Could Be Key to Fighting Brain Cancer Highlights Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
Woman experiencing pain related to recurrent pericarditis -- Image credit: Art_Photo | stock.adobe.com
Pharmacist assisting a patient with pericarditis -- Image credit: Yuri Arcurs/peopleimages.com | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Related Content
Blood plasma as a hope for treatment of coronavirus infection. Syringe with blood plasma in a hand in a blue medical glove against the sky. Platelet-Rich plasma preparation.
February 21st 2025

Administering Plasma Therapy Requires Pharmacist Collaboration With Specialty Care Team

Luke Halpern, Assistant Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
ACTIVATE-Kids Study Demonstrates Efficacy of Oral Therapy for Children With PK Deficiency
February 20th 2025

ACTIVATE-Kids Study Demonstrates Efficacy of Oral Therapy for Children With PK Deficiency

Aislinn Antrim, Managing Editor
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations
January 25th 2024

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Parkinson and alzheimer female senior elderly patient hand with physician doctor exam in hospice care room.
February 16th 2025

FDA Grants Fast Track Designation to Amlenetug for Possible Treatment of Multiple System Atrophy

Luke Halpern, Assistant Editor
Blood sample with positive diagnosis of Hemophilia. Doctor holding Blood tube positive analysis to Haemophilia
February 15th 2025

Etranacogene Dezaparvovec-drlb Delivers Sustained, Increased Bleed Protection Compared With Prophylaxis in Hemophilia B

Luke Halpern, Assistant Editor